Psychemedics

-$0.21 (-2.90%) Today

-$0.01 (-0.14%) As of 12:36 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Psychemedics and other ETFs, options, and stocks.

About PMD

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana.

CEO

Raymond C. Kubacki

Employees

138

Headquarters

Acton, Massachusetts

Founded

1986

PMD Key Statistics

Market cap

Price-Earnings ratio

101.12

Dividend yield

3.54

Average volume

12.70K

High today

$7.39

Low today

$7.03

Open price

$7.39

Volume

17.38K

52 Week high

$8.90

52 Week low

$4.13

PMD News

Simply Wall St16h

Are Psychemedics Corporation's Mixed Financials Driving The Negative Sentiment?

It is hard to get excited after looking at Psychemedics' (NASDAQ:PMD) recent performance, when its stock has declined 14% over the past week. It seems that the

PMD Earnings

-$0.37

-$0.20

-$0.04

$0.13

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Mar 22, After Hours

Why Robinhood?

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. View more

Are Psychemedics Corporation's Mixed Financials Driving The Negative Sentiment?

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana.